194 related articles for article (PubMed ID: 35591944)
1. Site-Specific Regulation of Sulfatase and Aromatase Pathways for Estrogen Production in Endometriosis.
Da Costa KA; Malvezzi H; Dobo C; Neme RM; Filippi RZ; Aloia TPA; Prado ER; Meola J; Piccinato CA
Front Mol Biosci; 2022; 9():854991. PubMed ID: 35591944
[TBL] [Abstract][Full Text] [Related]
2. Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells.
Piccinato CA; Neme RM; Torres N; Sanches LR; Derogis PBMC; Brudniewski HF; Rosa E Silva JC; Ferriani RA
J Steroid Biochem Mol Biol; 2016 Apr; 158():117-126. PubMed ID: 26723541
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of steroidogenic enzymes according to endometriosis type.
Colette S; Defrère S; Van Kerk O; Van Langendonckt A; Dolmans MM; Donnez J
Fertil Steril; 2013 Dec; 100(6):1642-9. PubMed ID: 24012197
[TBL] [Abstract][Full Text] [Related]
4. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
Zeitoun K; Takayama K; Michael MD; Bulun SE
Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
[TBL] [Abstract][Full Text] [Related]
6. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
7. Estrogen metabolizing enzymes in endometrium and endometriosis.
Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor and aromatase expression in baboon endometriotic lesions.
Fazleabas AT; Brudney A; Chai D; Langoi D; Bulun SE
Fertil Steril; 2003 Sep; 80 Suppl 2():820-7. PubMed ID: 14505759
[TBL] [Abstract][Full Text] [Related]
9. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G
Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205
[TBL] [Abstract][Full Text] [Related]
10. Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells.
Qi Q; Liu X; Zhang Q; Guo SW
Sci Rep; 2020 Jan; 10(1):1281. PubMed ID: 31992765
[TBL] [Abstract][Full Text] [Related]
11. Aromatase expression in endometriosis.
Noble LS; Simpson ER; Johns A; Bulun SE
J Clin Endocrinol Metab; 1996 Jan; 81(1):174-9. PubMed ID: 8550748
[TBL] [Abstract][Full Text] [Related]
12. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.
Bulun SE; Zeitoun K; Takayama K; Noble L; Michael D; Simpson E; Johns A; Putman M; Sasano H
Endocr Relat Cancer; 1999 Jun; 6(2):293-301. PubMed ID: 10731122
[TBL] [Abstract][Full Text] [Related]
13. Dienogest reduces HSD17β1 expression and activity in endometriosis.
Mori T; Ito F; Matsushima H; Takaoka O; Koshiba A; Tanaka Y; Kusuki I; Kitawaki J
J Endocrinol; 2015 May; 225(2):69-76. PubMed ID: 25767055
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy.
Purohit A; Fusi L; Brosens J; Woo LW; Potter BV; Reed MJ
Hum Reprod; 2008 Feb; 23(2):290-7. PubMed ID: 18056119
[TBL] [Abstract][Full Text] [Related]
15. Functional Expression of FSH Receptor in Endometriotic Lesions.
Ponikwicka-Tyszko D; Chrusciel M; Stelmaszewska J; Bernaczyk P; Sztachelska M; Sidorkiewicz I; Doroszko M; Tomaszewski J; Tapanainen JS; Huhtaniemi I; Wolczynski S; Rahman NA
J Clin Endocrinol Metab; 2016 Jul; 101(7):2905-14. PubMed ID: 27224263
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of CYP1A1 and CYP1B1 in ovarian/peritoneal endometriotic lesions.
Piccinato CA; Neme RM; Torres N; Sanches LR; Cruz Derogis PB; Brudniewski HF; E Silva JC; Ferriani RA
Reproduction; 2016 Jun; 151(6):683-92. PubMed ID: 27012269
[TBL] [Abstract][Full Text] [Related]
17. Absence of aromatase protein and mRNA expression in endometriosis.
Colette S; Lousse JC; Defrère S; Curaba M; Heilier JF; Van Langendonckt A; Mestdagt M; Foidart JM; Loumaye E; Donnez J
Hum Reprod; 2009 Sep; 24(9):2133-41. PubMed ID: 19493871
[TBL] [Abstract][Full Text] [Related]
18. Enhanced UGT1A1 Gene and Protein Expression in Endometriotic Lesions.
Piccinato CA; Neme RM; Torres N; Victor EDS; Brudniewski HF; Silva JCRE; Ferriani RA
Reprod Sci; 2018 Sep; 25(9):1371-1375. PubMed ID: 29540112
[TBL] [Abstract][Full Text] [Related]
19. Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line.
Beranič N; Rižner TL
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):303-10. PubMed ID: 22878119
[TBL] [Abstract][Full Text] [Related]
20. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism.
Delvoux B; Groothuis P; D'Hooghe T; Kyama C; Dunselman G; Romano A
J Clin Endocrinol Metab; 2009 Mar; 94(3):876-83. PubMed ID: 19088158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
